View Item 

Show simple item record

A comparative prospective observational study of children and adults with immune thrombocytopenia: 2‐year follow‐up

dc.contributor.authorSchifferli, Alexandra
dc.contributor.authorHolbro, Andreas
dc.contributor.authorChitlur, Meera
dc.contributor.authorCoslovsky, Michael
dc.contributor.authorImbach, Paul
dc.contributor.authorDonato, Hugo
dc.contributor.authorElalfy, Mohsen
dc.contributor.authorGraciela, Elena
dc.contributor.authorGrainger, John
dc.contributor.authorHolzhauer, Susanne
dc.contributor.authorRiccheri, Cecilia
dc.contributor.authorRodeghiero, Francesco
dc.contributor.authorRuggeri, Marco
dc.contributor.authorTamary, Hannah
dc.contributor.authorUglova, Tatjana
dc.contributor.authorWu, Runhui
dc.contributor.authorKühne, Thomas
dc.date.accessioned2018-06-11T17:59:42Z
dc.date.available2019-08-01T19:53:23Zen
dc.date.issued2018-06
dc.identifier.citationSchifferli, Alexandra; Holbro, Andreas; Chitlur, Meera; Coslovsky, Michael; Imbach, Paul; Donato, Hugo; Elalfy, Mohsen; Graciela, Elena; Grainger, John; Holzhauer, Susanne; Riccheri, Cecilia; Rodeghiero, Francesco; Ruggeri, Marco; Tamary, Hannah; Uglova, Tatjana; Wu, Runhui; Kühne, Thomas (2018). "A comparative prospective observational study of children and adults with immune thrombocytopenia: 2‐year follow‐up." American Journal of Hematology 93(6): 751-759.
dc.identifier.issn0361-8609
dc.identifier.issn1096-8652
dc.identifier.urihttps://hdl.handle.net/2027.42/144256
dc.description.abstractComparative clinical studies of children and adults with immune thrombocytopenia (ITP) are poorly covered in the literature. However, the accepted classification of ITP—childhood ITP and adult ITP—results in considerable differences in treatment protocols and practice guidelines. The analysis of the Pediatric and Adult Registry on Chronic ITP (PARC‐ITP) of patients at first presentation demonstrated fewer differences in clinical and laboratory findings at initial diagnosis between children and adults than expected. The present report of 2‐year follow‐up data supports the hypothesis that there are common aspects of childhood and adult ITP. Data of 3360 children and 420 adults were collected during the time of 2004 until 2015 at initial diagnosis. Follow‐up information was available for 51% and 33% of children and 66% and 49% of adults at 12‐ and 24‐months, respectively. Similarities were found in unexpected areas of ITP, such as the rate of late remission at 12 and 24 months, reported bleeding sites, platelet count in bleeders, and the frequency of treated patients with persistent or chronic ITP. Differences were confirmed for the overall rate of remission and treatment modalities. Unexpected differences were found in the percentage of nonbleeders, with more adults in the nonbleeder group. More studies are needed to investigate different age groups with the aim to optimize their management.
dc.publisherLippincott Williams & Wilkins
dc.publisherWiley Periodicals, Inc.
dc.titleA comparative prospective observational study of children and adults with immune thrombocytopenia: 2‐year follow‐up
dc.typeArticleen_US
dc.rights.robotsIndexNoFollow
dc.subject.hlbsecondlevelOncology and Hematology
dc.subject.hlbsecondlevelMolecular, Cellular and Developmental Biology
dc.subject.hlbtoplevelScience
dc.subject.hlbtoplevelHealth Sciences
dc.description.peerreviewedPeer Reviewed
dc.description.bitstreamurlhttps://deepblue.lib.umich.edu/bitstream/2027.42/144256/1/ajh25086.pdf
dc.description.bitstreamurlhttps://deepblue.lib.umich.edu/bitstream/2027.42/144256/2/ajh25086_am.pdf
dc.identifier.doi10.1002/ajh.25086
dc.identifier.sourceAmerican Journal of Hematology
dc.identifier.citedreferenceImbach P, Kühne T, Müller D, et al. Childhood ITP: 12 months follow‐up data from the prospective registry I of the Intercontinental Childhood ITP Study Group (ICIS). Pediatr Blood Cancer. 2006; 46 ( 3 ): 351 – 356.
dc.identifier.citedreferenceIntercontinental Childhood ITP Study Group (ICIS): State‐of‐the‐Art Expert Meeting on ITP, September 2003—Buergenstock, Switzerland. J Pediatric Hematol Oncol. 2003; 25: S1 – 84.
dc.identifier.citedreference2nd ICIS Expert Meeting 2006 on critical issues and future development of research in ITP. Pediatr Blood Cancer. 2006; 47: 649 – 745.
dc.identifier.citedreference3rd ICIS Expert Meeting in Basel, Switzerland, September 2009. Ann Hematol. 2010; 89 ( Suppl ): 1 – 109.
dc.identifier.citedreference4th ICIS Expert Meeting in Montreux, Switzerland, September 2012. Semin Hematol. 2013; 50 ( Suppl 1 ): S1 – S26.
dc.identifier.citedreference5th ICIS Expert Meeting on Immunomodulation and Management in ITP and Other Autoimmune Disorders, September 2015—Flüeli‐Ranft, Switzerland. Semin Hematol. 2016; 53 ( Suppl 1 ): S1 – S72.
dc.identifier.citedreferenceRodeghiero F, Stasi R, Gernsheimer T, et al. Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group. Blood. 2009; 113 ( 11 ): 2386 – 2393.
dc.identifier.citedreferenceKühne T. Update on the intercontinental cooperative ITP study group (ICIS) and on the pediatric and adult registry on chronic ITP (PARC ITP). Pediatr Blood Cancer. 2013; 60 ( S1 ): S15 – S18.
dc.identifier.citedreferenceR Development Core Team ( 2017 ). R: a language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. URL http://www.R-project.org.
dc.identifier.citedreferenceSaeidi S, Jaseb K, Asnafi AA, et al. Immune thrombocytopenic purpura in children and adults: a comparative retrospective study in IRAN. Int J Hematol Oncol Stem Cell Res. 2014; 8 ( 3 ): 30 – 36.
dc.identifier.citedreferenceVianelli N, Valdrè L, Fiacchini M, et al. Long‐term follow‐up of idiopathic thrombocytopenic purpura in 310 patients. Haematologica. 2001; 86 ( 5 ): 504 – 509.
dc.identifier.citedreferenceFogarty PF, Segal JB. The epidemiology of immune thrombocytopenic purpura. Curr Opin Hematol. 2007; 14 ( 5 ): 515 – 519.
dc.identifier.citedreferenceKühne T. Immune thrombocytopenia. UNI‐MED Verlag. 2010.
dc.identifier.citedreferenceColman RW, Marder VJ, Clowes AW, George JN, Goldhaber SZ. Hemostasis and Thrombosis: Basic Principles and Clinical Practice. Philadelphia: Lippincott Williams & Wilkins; 2006. 1 – 1822.
dc.identifier.citedreferenceCohen YC, Djulbegovic B, Shamai‐Lubovitz O, Mozes B. The bleeding risk and natural history of idiopathic thrombocytopenic purpura in patients with persistent low platelet counts. Arch Intern Med. 2000; 160 ( 11 ): 1630 – 1638.
dc.identifier.citedreferenceMahévas M, Michel M, Godeau B. How we manage immune thrombocytopenia in the elderly. Br J Haematol. 2016; 173 ( 6 ): 844 – 856.
dc.identifier.citedreferenceSutor AH, Harms A, Kaufmehl K. Acute immune thrombocytopenia (ITP) in childhood: retrospective and prospective survey in Germany. Semin Thromb Hemost. 2001; 27 ( 03 ): 253 – 267.
dc.identifier.citedreferenceAbrahamson PE, Hall SA, Feudjo‐Tepie M, Mitrani‐Gold FS, Logie J. The incidence of idiopathic thrombocytopenic purpura among adults: a population‐based study and literature review. Eur J Haematol. 2009; 83 ( 2 ): 83 – 89.
dc.identifier.citedreferenceDeane S, Teuber SS, Gershwin ME. The geoepidemiology of immune thrombocytopenic purpura. Autoimmun Rev. 2010; 9 ( 5 ): A342 – A349.
dc.identifier.citedreferenceSailer T, Lechner K, Panzer S, Kyrle PA, Pabinger I. The course of severe autoimmune thrombocytopenia in patients not undergoing splenectomy. Haematologica. 2006; 91 ( 8 ): 1041 – 1045.
dc.identifier.citedreferenceNeunert CE, Buchanan GR, Imbach P, Intercontinental Cooperative ITP Study Group Registry II Participants, et al. Bleeding manifestations and management of children with persistent and chronic immune thrombocytopenia: data from the Intercontinental Cooperative ITP Study Group (ICIS). Blood. 2013; 121 ( 22 ): 4457 – 4462.
dc.identifier.citedreferenceRodeghiero F, Michel M, Gernsheimer T, et al. Standardization of bleeding assessment in immune thrombocytopenia: report from the International Working Group. Blood. 2013; 121 ( 14 ): 2596 – 2606.
dc.identifier.citedreferenceKumar M, Dutta S, Bhattyacharyya M. Application of ITP‐BAT bleeding score in clinical practice. Int J Hematol. 2015; 101 ( 2 ): 207 – 208.
dc.identifier.citedreferenceMcMillan R, Durette C. Long‐term outcomes in adults with chronic ITP after splenectomy failure. Blood. 2004; 104 ( 4 ): 956 – 960.
dc.identifier.citedreferenceBizzoni L, Mazzucconi MG, Gentile M, et al. Idiopathic thrombocytopenic purpura (ITP) in the elderly: clinical course in 178 patients. Eur J Haematol. 2006; 76 ( 3 ): 210 – 216.
dc.identifier.citedreferenceBourgeois E, Caulier MT, Delarozee C, et al. Long‐term follow‐up of chronic autoimmune thrombocytopenic purpura refractory to splenectomy: a prospective analysis. Br J Haematol. 2003; 120 ( 6 ): 1079 – 1088.
dc.identifier.citedreferenceNeunert C, Noroozi N, Norman G, et al. Severe bleeding events in adults and children with primary immune thrombocytopenia: a systematic review. J Thromb Haemost. 2015; 13 ( 3 ): 457 – 464.
dc.identifier.citedreferenceMichel M, Rauzy OB, Thoraval FR, et al. Characteristics and outcome of immune thrombocytopenia in elderly: results from a single center case‐controlled study. Am J Hematol. 2011; 86 ( 12 ): 980 – 984.
dc.identifier.citedreferencePsaila B, Petrovic A, Page LK, Menell J, Schonholz M, Bussel JB. Intracranial hemorrhage (ICH) in children with immune thrombocytopenia (ITP): study of 40 cases. Blood. 2009; 114 ( 23 ): 4777 – 4783.
dc.identifier.citedreferenceButros LJ, Bussel JB. Intracranial hemorrhage in immune thrombocytopenic purpura: a retrospective analysis. J Pediatr Hematol Oncol. 2003; 25 ( 8 ): 660 – 664.
dc.identifier.citedreferenceMichele P, Lambert MD, Terry B, Gernsheimer MD. Clinical updates in adult immune thrombocytopenia (ITP). Blood. 2017; 129 ( 21 ): 2829 – 2835.
dc.identifier.citedreferenceGeorge JN, Kojouri K, Perdue JJ, Vesely SK. Management of patients with chronic, refractory idiopathic thrombocytopenic purpura. Semin Hematol. 2000; 37 ( 3 ): 290 – 298. Review.
dc.identifier.citedreferencePalandri F, Polverelli N, Sollazzo D, et al. Have splenectomy rate and main outcomes of ITP changed after the introduction of new treatments? A monocentric study in the outpatient setting during 35 years. Am J Hematol. 2016; 91 ( 4 ): E267 – E272.
dc.identifier.citedreferenceCooper N, Bussel J. The pathogenesis of immune thrombocytopaenic purpura. Br J Haematol. 2006; 133 ( 4 ): 364 – 374.
dc.identifier.citedreferenceJohnsen J. Pathogenesis in immune thrombocytopenia: new insights. Hematol Am Soc Hematol Educ Program. 2012; 2012: 306 – 312.
dc.identifier.citedreferenceShulman NR, Marder VJ, Weinrach RS. Similarities between known antiplatelet antibodies and the factor responsible for thrombocytopenia in idiopathic purpura. Physiologic, serologic and isotopic studies. Ann N Y Acad Sci. 1965; 124 ( 2 ): 499 – 542.
dc.identifier.citedreferenceKhodadi E, Asnafi AA, Shahrabi S, Shahjahani M, Saki N. Bone marrow niche in immune thrombocytopenia: a focus on megakaryopoiesis. Ann Hematol. 2016; 95 ( 11 ): 1765 – 1776.
dc.identifier.citedreferenceOlsson B, Andersson PO, Jernås M. T‐cell mediated cytotoxicity toward platelets in chronic idiopathic thrombocytopenic purpura. Nat Med. 2003; 9 ( 9 ): 1123 – 1124.
dc.identifier.citedreferenceCines DB, Blanchette VS. Immune thrombocytopenic purpura. N Engl J Med. 2002; 346 ( 13 ): 995 – 1008.
dc.identifier.citedreferenceGeorge JN, Woolf SH, Raskob GE, et al. Idiopathic thrombocytopenic purpura: a practice guideline developed by explicit methods for The American Society of Hematology. Blood. 1996; 88 ( 1 ): 3 – 40.
dc.identifier.citedreferenceBritish Committee for Standards in Haematology General Haematology Task Force. Guidelines for the investigation and management of idiopathic thrombocytopenic purpura in adults, children and in pregnancy. Br J Haematol. 2003; 120 ( 4 ): 574 – 596.
dc.identifier.citedreferenceProvan D, Stasi R, Newland AC, et al. International consensus report on the investigation and management of primary immune thrombocytopenia. Blood. 2010; 115 ( 2 ): 168 – 186.
dc.identifier.citedreferenceNeunert C, Lim W, Crowther M, Cohen A, Solberg L, Jr, Crowther MA. American Society of Hematology The American Society of Hematology 2011 evidence‐based practice guideline for immune thrombocytopenia. Blood. 2011; 117 ( 16 ): 4190 – 4207.
dc.identifier.citedreferenceMoulis G, Palmaro A, Montastruc JL, Godeau B, Lapeyre‐Mestre M, Sailler L. Epidemiology of incident immune thrombocytopenia: a nationwide population‐based study in France. Blood. 2014; 124 ( 22 ): 3308 – 3315.
dc.identifier.citedreferenceKühne T, Berchtold W, Michaels LA, et al. Newly diagnosed immune thrombocytopenia in children and adults: a comparative prospective observational registry of the Intercontinental Cooperative Immune Thrombocytopenia Study Group. Intercontinental Cooperative ITP Study Group. Haematologica. 2011; 96 ( 12 ): 1831 – 1837.
dc.identifier.citedreferenceHeitink‐Pollé KM, Nijsten J, Boonacker CW, de Haas M, Bruin MC. Clinical and laboratory predictors of chronic immune thrombocytopenia in children: a systematic review and meta‐analysis. Blood. 2014; 124 ( 22 ): 3295 – 3307.
dc.identifier.citedreferenceGrimaldi‐Bensouda L, Nordon C, Michel M, Group for the PGRx‐ITP Study, et al. Immune thrombocytopenia in adults: a prospective cohort study of clinical features and predictors of outcome. Haematologica. 2016; 101 ( 9 ): 1039 – 1045.
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
ajh25086.pdf
Size:
925.6KB
Format:
PDF
View/Open
Name:
ajh25086_am.pdf
Size:
603.9KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.